Cargando…
LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trial
OBJECTIVE: To compare the efficacy of the levonorgestrel-releasing intrauterine system (LNG-IUS) and oral norethisterone acetate (NET) for treatment of non-atypical endometrial hyperplasia in perimenopausal women. METHODS: One hundred and twenty perimenopausal women with non-atypical endometrial hyp...
Autores principales: | Abu Hashim, Hatem, Zayed, Abdelhady, Ghayaty, Essam, El Rakhawy, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644688/ https://www.ncbi.nlm.nih.gov/pubmed/23653829 http://dx.doi.org/10.3802/jgo.2013.24.2.128 |
Ejemplares similares
-
LNG-IUS treatment of non-atypical endometrial hyperplasia: Can Pipelle endometrial sampling be an accurate method of follow-up evaluation?
por: Kim, Mi Kyoung, et al.
Publicado: (2013) -
The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia
por: Chen, Xiaojun
Publicado: (2019) -
Efficacy of the LNG-IUS for treatment of endometrial hyperplasia and early stage endometrial cancer: Can biomarkers predict response?
por: Dore, Molly, et al.
Publicado: (2021) -
Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS
por: Bednarek, Paula H, et al.
Publicado: (2010) -
A controlled clinical trial comparing potent progestins, LNG‐IUS and dienogest, for the treatment of women with adenomyosis
por: Ota, Ikuko, et al.
Publicado: (2021)